Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011. (Q44892386)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011. |
scientific article |
Statements
1 reference
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011. (English)
1 reference
1 reference
John C Byrd
1 reference
Frederick R Appelbaum
1 reference
Kanti Rai
1 reference
Bercedis L Peterson
1 reference
Vicki A Morrison
1 reference
Jonathan E Kolitz
1 reference
Lois Shepherd
1 reference
John D Hines
1 reference
Charles A Schiffer
1 reference
11 May 2004
1 reference
1 reference
105
1 reference
1
1 reference
49-53
1 reference
Identifiers
1 reference
1 reference